Measuring tumor extent based on subtypes using magnetic resonance imaging: Radiologic-pathologic discordance and high positive margin rates in breast cancer

Soong June Bae, Sung Gwe Ahn, Chang Ik Yoon, Ban Seok Yang, Hak Woo Lee, Eun Ju Son, Joon Jeong

Research output: Contribution to journalArticle

Abstract

Purpose: We evaluated the clinical value of breast magnetic resonance imaging (MRI) in patients who underwent breast-conserving surgery (BCS). The degree of correlation between pathology size and MRI or ultrasonography (US) size was compared based on breast cancer subtypes. In addition, we investigated the positive margin rates. Methods: Patients with invasive breast cancer who underwent preoperative breast MRI and US between 2011 and 2016 were included in the study. Lin's concordance correlation coefficient was used to measure the correlation between MRI or US andpathologic tumor extent. Tumor extent was defined as pathologic tumor size, including in situ carcinoma. Margin positivity was assessed based on frozen-section examination. Results: A total of 516 patients with a single tumor who underwent BCS were included in the study. The correlation between pathologic size and MRI was significantly higher than that of US (r = 0.6975 vs. 0.6211, p = 0.001). The superiority of MRI over US in measuring the pathologic extent was only observed in triple-negative breast cancer (TNBC; r = 0.8089 vs. 0.6014, p < 0.001). The agreement between MRI or US and tumor extent was low for the human epidermal growth factor receptor 2 (HER2)-positive subtype (MRI: 0.5243, US: 0.4898). Moreover, the positive margin rate was higher in the HER2-positive subtype than in the others (luminal/HER2-negative: 11.6%, HER2-positive: 23.2%, TNBC: 17.8%, p = 0.019). The post hoc analysis showed that the HER2-positive subtype was more likely to show positive margins than the luminal/HER2-negative subtype (p = 0.007). Conclusion: Breast MRI was superior to US in the preoperative assessment of the pathologic extent of tumor size; this was most evident in TNBC. For HER2-positive tumors, imaging-pathologic discordance resulted in higher positive margin rates than that with other subtypes.

Original languageEnglish
Pages (from-to)453-463
Number of pages11
JournalJournal of Breast Cancer
Volume22
Issue number3
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Ultrasonography
Magnetic Resonance Imaging
Breast Neoplasms
Neoplasms
Breast
Segmental Mastectomy
Triple Negative Breast Neoplasms
Carcinoma in Situ
Frozen Sections
human ERBB2 protein
Pathology

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Bae, Soong June ; Ahn, Sung Gwe ; Yoon, Chang Ik ; Yang, Ban Seok ; Lee, Hak Woo ; Son, Eun Ju ; Jeong, Joon. / Measuring tumor extent based on subtypes using magnetic resonance imaging : Radiologic-pathologic discordance and high positive margin rates in breast cancer. In: Journal of Breast Cancer. 2019 ; Vol. 22, No. 3. pp. 453-463.
@article{4410c6064166491696e2cb0ef2d7d1d6,
title = "Measuring tumor extent based on subtypes using magnetic resonance imaging: Radiologic-pathologic discordance and high positive margin rates in breast cancer",
abstract = "Purpose: We evaluated the clinical value of breast magnetic resonance imaging (MRI) in patients who underwent breast-conserving surgery (BCS). The degree of correlation between pathology size and MRI or ultrasonography (US) size was compared based on breast cancer subtypes. In addition, we investigated the positive margin rates. Methods: Patients with invasive breast cancer who underwent preoperative breast MRI and US between 2011 and 2016 were included in the study. Lin's concordance correlation coefficient was used to measure the correlation between MRI or US andpathologic tumor extent. Tumor extent was defined as pathologic tumor size, including in situ carcinoma. Margin positivity was assessed based on frozen-section examination. Results: A total of 516 patients with a single tumor who underwent BCS were included in the study. The correlation between pathologic size and MRI was significantly higher than that of US (r = 0.6975 vs. 0.6211, p = 0.001). The superiority of MRI over US in measuring the pathologic extent was only observed in triple-negative breast cancer (TNBC; r = 0.8089 vs. 0.6014, p < 0.001). The agreement between MRI or US and tumor extent was low for the human epidermal growth factor receptor 2 (HER2)-positive subtype (MRI: 0.5243, US: 0.4898). Moreover, the positive margin rate was higher in the HER2-positive subtype than in the others (luminal/HER2-negative: 11.6{\%}, HER2-positive: 23.2{\%}, TNBC: 17.8{\%}, p = 0.019). The post hoc analysis showed that the HER2-positive subtype was more likely to show positive margins than the luminal/HER2-negative subtype (p = 0.007). Conclusion: Breast MRI was superior to US in the preoperative assessment of the pathologic extent of tumor size; this was most evident in TNBC. For HER2-positive tumors, imaging-pathologic discordance resulted in higher positive margin rates than that with other subtypes.",
author = "Bae, {Soong June} and Ahn, {Sung Gwe} and Yoon, {Chang Ik} and Yang, {Ban Seok} and Lee, {Hak Woo} and Son, {Eun Ju} and Joon Jeong",
year = "2019",
month = "1",
day = "1",
doi = "10.4048/jbc.2019.22.e36",
language = "English",
volume = "22",
pages = "453--463",
journal = "Journal of Breast Cancer",
issn = "1738-6756",
publisher = "Korean Breast Cancer Society",
number = "3",

}

Measuring tumor extent based on subtypes using magnetic resonance imaging : Radiologic-pathologic discordance and high positive margin rates in breast cancer. / Bae, Soong June; Ahn, Sung Gwe; Yoon, Chang Ik; Yang, Ban Seok; Lee, Hak Woo; Son, Eun Ju; Jeong, Joon.

In: Journal of Breast Cancer, Vol. 22, No. 3, 01.01.2019, p. 453-463.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Measuring tumor extent based on subtypes using magnetic resonance imaging

T2 - Radiologic-pathologic discordance and high positive margin rates in breast cancer

AU - Bae, Soong June

AU - Ahn, Sung Gwe

AU - Yoon, Chang Ik

AU - Yang, Ban Seok

AU - Lee, Hak Woo

AU - Son, Eun Ju

AU - Jeong, Joon

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: We evaluated the clinical value of breast magnetic resonance imaging (MRI) in patients who underwent breast-conserving surgery (BCS). The degree of correlation between pathology size and MRI or ultrasonography (US) size was compared based on breast cancer subtypes. In addition, we investigated the positive margin rates. Methods: Patients with invasive breast cancer who underwent preoperative breast MRI and US between 2011 and 2016 were included in the study. Lin's concordance correlation coefficient was used to measure the correlation between MRI or US andpathologic tumor extent. Tumor extent was defined as pathologic tumor size, including in situ carcinoma. Margin positivity was assessed based on frozen-section examination. Results: A total of 516 patients with a single tumor who underwent BCS were included in the study. The correlation between pathologic size and MRI was significantly higher than that of US (r = 0.6975 vs. 0.6211, p = 0.001). The superiority of MRI over US in measuring the pathologic extent was only observed in triple-negative breast cancer (TNBC; r = 0.8089 vs. 0.6014, p < 0.001). The agreement between MRI or US and tumor extent was low for the human epidermal growth factor receptor 2 (HER2)-positive subtype (MRI: 0.5243, US: 0.4898). Moreover, the positive margin rate was higher in the HER2-positive subtype than in the others (luminal/HER2-negative: 11.6%, HER2-positive: 23.2%, TNBC: 17.8%, p = 0.019). The post hoc analysis showed that the HER2-positive subtype was more likely to show positive margins than the luminal/HER2-negative subtype (p = 0.007). Conclusion: Breast MRI was superior to US in the preoperative assessment of the pathologic extent of tumor size; this was most evident in TNBC. For HER2-positive tumors, imaging-pathologic discordance resulted in higher positive margin rates than that with other subtypes.

AB - Purpose: We evaluated the clinical value of breast magnetic resonance imaging (MRI) in patients who underwent breast-conserving surgery (BCS). The degree of correlation between pathology size and MRI or ultrasonography (US) size was compared based on breast cancer subtypes. In addition, we investigated the positive margin rates. Methods: Patients with invasive breast cancer who underwent preoperative breast MRI and US between 2011 and 2016 were included in the study. Lin's concordance correlation coefficient was used to measure the correlation between MRI or US andpathologic tumor extent. Tumor extent was defined as pathologic tumor size, including in situ carcinoma. Margin positivity was assessed based on frozen-section examination. Results: A total of 516 patients with a single tumor who underwent BCS were included in the study. The correlation between pathologic size and MRI was significantly higher than that of US (r = 0.6975 vs. 0.6211, p = 0.001). The superiority of MRI over US in measuring the pathologic extent was only observed in triple-negative breast cancer (TNBC; r = 0.8089 vs. 0.6014, p < 0.001). The agreement between MRI or US and tumor extent was low for the human epidermal growth factor receptor 2 (HER2)-positive subtype (MRI: 0.5243, US: 0.4898). Moreover, the positive margin rate was higher in the HER2-positive subtype than in the others (luminal/HER2-negative: 11.6%, HER2-positive: 23.2%, TNBC: 17.8%, p = 0.019). The post hoc analysis showed that the HER2-positive subtype was more likely to show positive margins than the luminal/HER2-negative subtype (p = 0.007). Conclusion: Breast MRI was superior to US in the preoperative assessment of the pathologic extent of tumor size; this was most evident in TNBC. For HER2-positive tumors, imaging-pathologic discordance resulted in higher positive margin rates than that with other subtypes.

UR - http://www.scopus.com/inward/record.url?scp=85073463838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073463838&partnerID=8YFLogxK

U2 - 10.4048/jbc.2019.22.e36

DO - 10.4048/jbc.2019.22.e36

M3 - Article

AN - SCOPUS:85073463838

VL - 22

SP - 453

EP - 463

JO - Journal of Breast Cancer

JF - Journal of Breast Cancer

SN - 1738-6756

IS - 3

ER -